Although our study only describes the intracellular activity of IL-37b on the Smad3 signaling in HCC, it is conceivable that IL-37b secretion by liver nonparenchymal cells may also play an anticancer effect via extracellular signal transduction. This evidence concerns the gene SMAD3 and hepatocellular carcinoma.